Resultados da busca - Vanesa, Gregorc

Refinar Resultados
  1. 1
    Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example

    Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example por Angelo Corti, Flavio Curnis, Gilda Rossoni, Fabrizio Marcucci, Vanesa Gregorc

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Mechanisms of resistance to osimertinib

    Mechanisms of resistance to osimertinib por Chiara Lazzari, Vanesa Gregorc, Niki Karachaliou, Rafael Rosell, Mariacarmela Santarpía

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Targeted Therapies in Early Stage NSCLC: Hype or Hope?

    Targeted Therapies in Early Stage NSCLC: Hype or Hope? por Alex Friedlaender, Alfredo Addeo, Alessandro Russo, Vanesa Gregorc, Diego Cortinovis, Christian Rolfo

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial

    Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial por Giovanni Luca Ceresoli, Federico Cappuzzo, Vanesa Gregorc, Stefania Bartolini, Lucio Crinò, Emmanuel Villa

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    KRAS in NSCLC: State of the Art and Future Perspectives

    KRAS in NSCLC: State of the Art and Future Perspectives por Priscilla Cascetta, Arianna Marinello, Chiara Lazzari, Vanesa Gregorc, David Planchard, Roberto Bianco, Nicola Normanno, Alessandro Morabito

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  6. 6
    Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?

    Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer? por Chiara Lazzari, Niki Karachaliou, Alessandra Bulotta, Mariagrazia Viganò, Aurora Mirabile, Elena Brioschi, Mariacarmela Santarpía, Luca Gianni, Rafael Rosell, Vanesa Gregorc

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  7. 7
    Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives

    Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives por Chiara Lazzari, Calogera Claudia Spagnolo, Giuliana Ciappina, Martina Di Pietro, Andrea Squeri, Maria Ilenia Passalacqua, Silvia Marchesi, Vanesa Gregorc, Mariacarmela Santarpía

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  8. 8
    Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib

    Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib por George Cusatis, Vanesa Gregorc, Jing Li, Anna Spreafico, Roxann Ingersoll, Jaap Verweij, Vienna Ludovini, Eugenio Villa, Manuel Hidalgo, Alex Sparreboom, Sharyn D. Baker

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies

    Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies por Fausto Petrelli, Chiara Lazzari, Raffaele Ardito, Karen Borgonovo, Alessandra Bulotta, Bárbara Conti, Mary Cabiddu, Jody Filippo Capitanio, Matteo Brighenti, Mara Ghilardi, Luca Gianni, Sandro Barni, Vanesa Gregorc

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  10. 10
    Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

    Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours por Vanesa Gregorc, Armando Santoro, E. Bennicelli, Cornelis J.A. Punt, Giovanni Citterio, Johanna N.H. Timmer-Bonte, Ferderico Caligaris Cappio, A. Lambiase, Claudio Bordignon, Carla M.L. van Herpen

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series

    Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series por Corrado Campochiaro, Nicola Farina, Alessandro Tomelleri, Roberto Ferrara, Chiara Lazzari, Giacomo De Luca, Alessandra Bulotta, Diego Signorelli, Anna Palmisano, Davide Vignale, Giovanni Peretto, Simone Sala, Antonio Esposito, Marina Chiara Garassino, Vanesa Gregorc, Lorenzo Dagna

    Publicado em 2021
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  12. 12
    Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer

    Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer por Federico Cappuzzo, Elisabetta Magrini, Giovanni Luca Ceresoli, Stefania Bartolini, Elisa Rossi, V. Ludovini, Vanesa Gregorc, C. Ligorio, Alessandra Cancellieri, Stefania Damiani, Anna Spreafico, Carlo Paties, L. Lombardo, C. Calandri, Guido Bellezza, Maurizio Tonato, Lucio Crinò

    Publicado em 2004
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Increased<i>HER2</i>Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients

    Increased<i>HER2</i>Gene Copy Number Is Associated With Response to Gefitinib Therapy in Epidermal Growth Factor Receptor–Positive Non–Small-Cell Lung Cancer Patients por Federico Cappuzzo, Marileila Varella‐Garcia, Hisayuki Shigematsu, I. Domenichini, Stefania Bartolini, Giovanni Luca Ceresoli, Elisa Rossi, Vienna Ludovini, Vanesa Gregorc, Luca Toschi, Wilbur A. Franklin, Lucio Crinò, Adi F. Gazdar, Paul A. Bunn, Fred R. Hirsch

    Publicado em 2005
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients: A Study of the Perugia Multidisciplinary Team for Thoracic Oncology

    Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients: A Study of the... por Vienna Ludovini, Lorenza Pistola, Vanesa Gregorc, Irene Floriani, Eliana Rulli, Simonetta Piattoni, Luciana Di Carlo, Antonia Semeraro, Samir Darwish, Francesca Romana Tofanetti, Lucia Stocchi, Zhasmina Mihaylova, Guido Bellezza, Rachele Del Sordo, G Daddi, Lucio Crinò, Maurizio Tonato

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer

    Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer por Federico Cappuzzo, Fred R. Hirsch, Elisa Rossi, Stefania Bartolini, Giovanni Luca Ceresoli, Lynne Bemis, Jerry Haney, Samir E. Witta, Kathleen D. Danenberg, I. Domenichini, Vienna Ludovini, Elisabetta Magrini, Vanesa Gregorc, Claudio Doglioni, Angelo Sidoni, Maurizio Tonato, Wilbur A. Franklin, Lucio Crinò, Paul A. Bunn, Marileila Varella‐Garcia

    Publicado em 2005
    Obter o texto integral
    Carta
    Salvar na lista
    Na minha lista:
  16. 16
    Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

    Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesotheliom... por Vanesa Gregorc, Paolo Andrea Zucali, Armando Santoro, Giovanni Luca Ceresoli, Giovanni Citterio, Tommaso Martino De Pas, Nicoletta Zilembo, Fabio De Vincenzo, Matteo Simonelli, Gilda Rossoni, Anna Spreafico, Maria Grazia Viganò, Floriana Fontana, Filippo de Braud, Emilio Bajetta, Federico Caligaris‐Cappio, Paolo Bruzzi, A. Lambiase, Claudio Bordignon

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial

    Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised... por Vanesa Gregorc, Silvia Novello, Chiara Lazzari, Sandro Barni, Michele Aieta, Manlio Mencoboni, Francesco Grossi, Tommaso De Pas, Filippo de Marinis, Alessandra Bearz, Irene Floriani, Valter Torri, Alessandra Bulotta, Angela Cattaneo, Julia Grigorieva, Maxim Tsypin, Joanna Roder, Claudio Doglioni, Matteo Giaj Levra, Fausto Petrelli, Silvia Foti, Mariagrazia Viganò, Angela Bachi, Heinrich Röder

    Publicado em 2014
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Mass Spectrometry to Classify Non–Small-Cell Lung Cancer Patients for Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Multicohort Cross-Institutional Study

    Mass Spectrometry to Classify Non–Small-Cell Lung Cancer Patients for Clinical Outcome After Treatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Multicoho... por Fumiko Taguchi, Benjamin Solomon, Vanesa Gregorc, Heinrich Röder, Robert J. Gray, Kazuo Kasahara, Makoto Nishio, Julie R. Brahmer, Anna Spreafico, Vienna Ludovini, Pierre P. Massion, Rafał Dziadziuszko, Joan H. Schiller, Julia Grigorieva, Maxim Tsypin, Stephen W. Hunsucker, Richard M. Caprioli, Mark W. Duncan, Fred R. Hirsch, Paul A. Bunn, David P. Carbone

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells

    Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells por Jiajia Tang, Quan Zheng, Wang Qi, Ya-Ru Zhao, Preeta Ananthanarayanan, Chiara Reina, Berina Šabanović, Ke Jiang, Ming-Hsin Yang, Clara Csilla Meny, Huimin Wang, Mette Ø. Agerbæk, Thomas Mandel Clausen, Tobias Gustavsson, Chenlei Wen, Felice Borghi, Alfredo Mellano, Elisabetta Fenocchio, Vanesa Gregorc, Anna Sapino, Thor G. Theander, Da Fu, Alexandra Aicher, Ali Salanti, Baiyong Shen, Christopher Heeschen

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

    COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study por Marina Chiara Garassino, Jennifer G. Whisenant, Li‐Ching Huang, Annalisa Trama, Valter Torri, Francesco Agustoni, Javier Baena, Giuseppe Luigi Banna, Rossana Berardi, Anna Bettini, Emilio Bria, Matteo Brighenti, Jacques Cadranel, Alessandro De Toma, Claudio Chini, Alessio Cortellini, Enriqueta Felip, Giovanna Finocchiaro, Pilar Garrido, Carlo Genova, Raffaele Giusti, Vanesa Gregorc, Francesco Grossi, Federica Grosso, Salvatore Intagliata, Nicla La Verde, Stephen V. Liu, Julien Mazières, Edoardo Mercadante, Olivier Michielin, Gabriele Minuti, Denis Moro‐Sibilot, Giulia Pasello, Antonio Passaro, Vieri Scotti, Piergiorgio Solli, Elisa Maria Stroppa, Marcello Tiseo, Giuseppe Viscardi, Luca Voltolini, Yi‐Long Wu, Silvia Zai, Véra Pancaldi, Anne‐Marie C. Dingemans, Jan P. van Meerbeeck, Fabrice Barlési, Heather A. Wakelee, Solange Peters, Leora Horn

    Publicado em 2020
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: